WHO Immunization Monitoring Academy Webinars



The World Health Organization (WHO) is currently hosting a series of webinars exploring specific topics in immunisation monitoring. These webinars are open to anyone with an interest in this area. Further information and details on registration can be found via the link below: Immunization Monitoring Academy: Webinars

New meningococcal resources



The Australian Academy of Science has released a new video detailing the devastating impact of meningococcal disease. To access this video, as well as other meningococcal information, please follow the link below: MVEC: Meningococcal disease and vaccines

Updated hepatitis B reference page



We have recently updated our hepatitis B reference page to incorporate the latest recommendations for serological testing, patients with impaired renal function as well as a new pathway for non-responders to the routine hepatitis B vaccine course. Please access the page below via the following link: MVEC: Hepatitis B

Menactra® and Prevenar 13® co-administration



Menactra® should not be administered on the same day as Prevenar 13®. Studies have shown that co-administration may result in a decreased immune response to some of the pneumococcal serotypes. If both vaccines are required, Prevenar 13® should be administered first followed by Menactra® at least 4 weeks later. If these vaccines are inadvertently administered … Continued

World Health Organisation- Rabies



The World Health Organisation (WHO) has updated its position on rabies immunisation for pre- and post-exposure prophylaxis. The following position paper provides a summary on rabies disease and vaccines and concludes with the current WHO position on the use of rabies vaccines worldwide. The systematic review can also be accessed below. For further information on rabies … Continued

Global Vaccine Safety



The Global Vaccine Safety Initiative was set up in 2011 by the World Health Organsiation (WHO) to ensure that all countries had strategies in place to ensure vaccine safety. The latest highlight is available via the following link and has some great information on Adverse Events Following Immunisation (AEFI) training in our region (WPRO). Global Vaccine … Continued

Commonwealth funded meningococcal ACWY vaccine for teens



Beginning in April 2019, meningococcal ACWY vaccines will be funded on the National Immunisation Program (NIP) for teenagers aged 15-19 years. In 2017 and 2018 Victorian teenagers have been offered meningococcal ACWY vaccine (Menactra®) as part of the school based program in a state funded initiative. This change to the NIP will ensure that teenagers across the country … Continued